Skip to main content

drug trial Archives

Novel treatment for Prader-Willi syndrome being tested at VUMC

Sep. 4, 2019—A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.

Read more


New drugs approved to fight idiopathic pulmonary fibrosis

Jan. 15, 2015—The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

Read more


Study tracks new end-stage renal disease therapy

Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more